Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report - Scorecard - MDSpire

Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report

  • By

  • Fu-Yi Wang

  • Li-Long Zhu

  • Cheng Ji

  • Jie Deng

  • Lu Han

  • Fei Song

  • Zhong Chen

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: Utilization of Patient-Derived Organotypic Tumor Spheroids to Inform Combination Immunotherapy Strategies in Advanced Hepatocellular Carcinoma: A Case Study

At a Glance

CategoryDetail
Condition
Key MechanismsRefine to emphasize the predictive capabilities of the PDOTS model.
Target Population
Care Setting

Key Highlights

  • additional_highlight

Guideline-Based Recommendations

Diagnosis

    Management

    • S
    • u
    • g
    • g
    • e
    • s
    • t
    • a
    • l
    • t
    • e
    • r
    • n
    • a
    • t
    • i
    • v
    • e
    • t
    • h
    • e
    • r
    • a
    • p
    • i
    • e
    • s
    • o
    • r
    • c
    • o
    • n
    • s
    • i
    • d
    • e
    • r
    • a
    • t
    • i
    • o
    • n
    • s
    • a
    • l
    • o
    • n
    • g
    • s
    • i
    • d
    • e
    • P
    • D
    • O
    • T
    • S
    • -
    • g
    • u
    • i
    • d
    • e
    • d
    • t
    • r
    • e
    • a
    • t
    • m
    • e
    • n
    • t
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • monitoring

        Related Resources & Content

        Original Source(s)

        Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report

        • by Fu-Yi Wang, Li-Long Zhu, Cheng Ji, Jie Deng, Lu Han, Fei Song, Zhong Chen

        • June 2, 2026

        Related Content

        Case Report: A rare case of over 45 years’ survival in a patient with tonsillar adenoid cystic carcinoma

        ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma

        Case Report: A rare triad of neoplasms: navigating synchronous accessory breast cancer, papillary thyroid carcinoma, and inflammatory nasal papilloma